Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier and into the brain tissue. Its focus is to address unmet medical needs with its proprietary Transcend Platform.
Price: $1.25 | Change: $-0.03 | %Change: -2.34%
Volume: 7,100 | Day High/Low: 1.32/1.25 | 52 Week High/Low: 1.50/0.89
View modes: 
1 star

Dosing study

Has the dosing study started? How many months is it expected to last? thanks  rate and reply
4.5 stars

Something Interesting about Ultrasound

Here's a link to some interesting stuff about using ultrasound in therapeutic ways. The link below comes from the latest CBC "Nature of Things" episode called, "Sonic Magic: more
4 stars

RE:RE:The New Patent

Hassy, both new patents include any derivitives or fragments of the antibodies and other drugs that they already cover. That means that Transcend-biosimilars and Transcend-generics are also more
3.5 stars

Another New Patent!

Yes, kids, there's another new patent. It was issued two weeks after the Her2/neu brain metastases patent. If the Her2/neu patent is the gateway to dominance of brain metastases commercial more
3.5 stars

RE:The New Patent

JD, Thanks in advance for your research into this. Based on the patent issued, would the generic drug markets run potentially run into breaching of our IP when herceptin's original patent more
3 stars

RE:RE:RE:heard this on the radio and thought it fitting advice.......

Jekyl Jekyl Jekyl, you've always taken everything you hear/read in press releases and videos at face value.  Hard to believe anybody could be so naive.  Throw in your propensity more
3 stars

RE:RE:RE:heard this on the radio and thought it fitting advice.......

Jekyl, maybe people have contempt for you because you are both contemptuous and contemptible.   And about you being the paragon of objectivity...   Bwwaaaahhhhh haa haa ha ha ha more
3 stars

RE:RE:heard this on the radio and thought it fitting advice.......

kayaker, kayaker, kayaker, that post had everything to do with the words i've heard and read over the last 12 to 15 months in videos and press releases. you know it and i know it. its a shame more
3 stars

RE:heard this on the radio and thought it fitting advice.......

Jekyl, this isn't the place to discuss your personal relationship(s).  Nobody cares. Please take it somewhere else.  rate and reply
4.5 stars

The New Patent

On November 10th, biOasis announced the issuance of its latest patent for the delivery of antibodies to the CNS for the treatment of Her2/neu brain metastases. The patent number is 9,150,846, more
2 stars

heard this on the radio and thought it fitting advice.......

that's right, get to the main attraction.......... a little less talk and a lot more action! {^youtubevideo|(width)425|(height)264|(rel)False|(url)|( more
4 stars

RE:RE:RE:RE:RE:News, Patent

The patent news release can now be found on the Bioasis website.  rate and reply
3.5 stars

RE:First Human Trials?? What are we to make of this?

This was discussed in length if you scroll down a little- here is a link to JD's post. I am more
3.5 stars

First Human Trials?? What are we to make of this?

Perhaps this is why BTI is being ignored in the market  rate and reply
5 stars

RE:RE:RE:RE:RE:RE:News, Patent

BTI often releases news after the market closes so you can take that one off your list. I don't think BTI has anything to do with stockhouse having the release or not. I think stockhouse more
3 stars

RE:RE:RE:RE:RE:News, Patent

1) the news was released after the market closed and 2) is not posted on it possible that someone wants this news release to have the smallest audience as possible? if so, why?  rate and reply
3 stars

RE:RE:RE:RE:News, Patent

This seems like really good news to me. Strange how it hasn't appeared on the stockhouse news feed. I wonder if this might be something a certain pharma has been waiting to see before making more
2.5 stars

RE:RE:RE:News, Patent

right now, the market book says $1.10 x $1.17 V:BTI Market Book By Order 08:52:38 Bid Ask Spec Time Broker ATS more
3.5 stars

RE:RE:News, Patent

can anybody actually begin to realize how much money that patent can be worth?????!!!!!  rate and reply
5 stars

RE:News, Patent

regardless of the price tommorrow ...this is a huge news here for trancend pep.....eyes have got to be on this after the news i just read  rate and reply

Stockhouse would like your help. Please click here.